Synergistic Chemo-Immunotherapy Using pH-Responsive Nanoparticles in Breast Cancer Treatment: In Vitro and In Vivo Studies

Kavya Sree Maravajjala, Milan Paul, Ritika Jaiswal, Vagesh Verma, Swati Biswas, Aniruddha Roy

Open source

DOI
10.1021/acs.molpharmaceut.4c00723
Published
2024-10-30
Container
Molecular Pharmaceutics
Publisher
American Chemical Society (ACS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.4c00723,
  title = {Synergistic Chemo-Immunotherapy Using pH-Responsive Nanoparticles in Breast Cancer Treatment: In Vitro and In Vivo Studies},
  author = {Kavya Sree Maravajjala and Milan Paul and Ritika Jaiswal and Vagesh Verma and Swati Biswas and Aniruddha Roy},
  year = {2024},
  journal = {Molecular Pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.4c00723},
  url = {https://doi.org/10.1021/acs.molpharmaceut.4c00723}
}

RIS

TY  - JOUR
TI  - Synergistic Chemo-Immunotherapy Using pH-Responsive Nanoparticles in Breast Cancer Treatment: In Vitro and In Vivo Studies
AU  - Kavya Sree Maravajjala
AU  - Milan Paul
AU  - Ritika Jaiswal
AU  - Vagesh Verma
AU  - Swati Biswas
AU  - Aniruddha Roy
PY  - 2024
JO  - Molecular Pharmaceutics
DO  - 10.1021/acs.molpharmaceut.4c00723
UR  - https://doi.org/10.1021/acs.molpharmaceut.4c00723
ER  - 

APA

Maravajjala, K. S., Paul, M., Jaiswal, R., Verma, V., Biswas, S., & Roy, A. (2024). Synergistic Chemo-Immunotherapy Using pH-Responsive Nanoparticles in Breast Cancer Treatment: In Vitro and In Vivo Studies. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00723

Source records